Indications
Prevention of skeletal-related events and treatment of tumour-induced hypercalcaemia.
Composition
- Active substance
- zoledronic acid
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Zoledronic acid Teva
- Active substance
- zoledronic acid
- ATC code
- M05BA08
- Therapeutic area
- Fractures, Bone, Cancer
- Marketing authorisation holder
- Teva B.V.
- Status
- Authorised
- EU authorisation
- 16 Aug 2012
- EMA product number